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Summary
Mutations in genes on the X chromosome are believed
to be responsible for the excess of males among indi-
viduals with mental retardation. Such genes are numer-
ous, certainly 1100, and cause both syndromal and non-
syndromal types of mental retardation. Clinical and
molecular studies have been conducted on the Mennon-
ite family with X-linked mental retardation (XLMR) re-
ported, in 1962, by Renpenning et al. The clinical phe-
notype includes severe mental retardation,microcephaly,
up-slanting palpebral fissures, small testes, and stature
shorter than that of nonaffected males. Major malfor-
mations, neuromuscular abnormalities, and behavioral
disturbances were not seen. Longevity is not impaired.
Carrier females do not show heterozygote manifesta-
tions. The syndrome maps to Xp11.2-p11.4, with a
maximum LOD score of 3.21 (recombination fraction
0) for markers between DXS1039 and DXS1068. Ren-
penning syndrome (also known as “MRXS8”; gene
RENS1, MIM 309500) shares phenotypic manifesta-
tions with several other XLMR syndromes, notably the
Sutherland-Haan syndrome. In none of these entities has
the responsible gene been isolated; hence, the possibility
that two or more of them may be allelic cannot be ex-
cluded at present.
Introduction
In 1962, Renpenning et al. (1962) reported mental re-
tardation affecting 20 males in three generations of a
Mennonite family in Canada. The founding couple had
emigrated from the Ukraine to Plum Coulee, Manitoba,
during the 1870s. From this location, subsequent gen-
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erations dispersed throughout the farmlands of central
and western Canada (Manitoba, Saskatchewan, Alberta,
and British Columbia). The founding mother is pre-
sumed to have carried the mutation for this type of X-
linked mental retardation (XLMR), since, in separate
marriages, she had daughters who had affected sons.
Affected males were described as well built and phys-
ically strong, with head circumferences at the lower lim-
its of normal and with somewhat prominent ears. They
learned to walk at age 2–3 years and said simple words
at age 3–4 years. With one exception, intelligence was
severely impaired, with IQ measurements of 13–45. Two
males had seizures, and two were blind (one in associ-
ation with bilateral colobomas). Carrier females showed
no abnormality.
Prior to Repenning et al.’s study, few families with
XLMR had been reported (Martin and Bell 1943; Allan
et al. 1944; Losowsky 1961), and, during the 1960s and
1970s, the designation “Renpenning syndrome” (gene
RENS1; MIM 309500 [http://www.ncbi.nlm.nih.gov/
htbin-post/Omim]) came to be used as a generic desig-
nation for XLMR, although some preferred to see the
term used only for nonsyndromic XLMR (Turner et al.
1971). Fox et al. (1980) restudied the family in 1980,
reviewed the phenotype, and excluded fragile X syn-
drome as the diagnosis, on the basis of negative cyto-
genetic analysis for the Xq27.3 fragile site. The family
has now been restudied by molecular techniques, and
the gene has been mapped to Xp11.2-p11.4.
Subjects and Methods
Case Reports
A partial pedigree is shown in figure 1. Renpenning
et al. (1962) reported 20 affected males, although one
male (V-18) was noted to be less severely involved. This
male had an IQ measurement of 70, had 12 years of
public schooling, and now works in a restaurant and
lives alone. One affected male (V-26) lived in Mexico
and was not evaluated. Eighteen males were severely
affected, with IQ measurements of 13–45, and were un-
able to attend school. Although some were able to per-
form simple farm tasks, most eventually were placed in
training schools or other institutions. Only one (III-11)
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Figure 1 Partial pedigree for kindred 8110. Bars over pedigree symbols denote individuals evaluated in the current study; asterisks above
pedigree symbols denote individuals for whom fixed tissues were available.
died during childhood. Two were blind, one case (III-3)
of unknown cause and one case (III-15) associated with
bilateral colobomas and cataracts. Three males had sei-
zures, and four had diabetes mellitus (table 1). An ad-
ditional male with mental retardation, who was related
through a normal male, was considered by Renpenning
et al. (1962) to be a coincidental occurrence and is not
shown on the pedigree. Obligate carriers were normal.
At the time of this study, four affected males (IV-11,
IV-15, V-4, and V-15) and the male with mild mental
impairment (V-18) were alive, and all were available for
examination and blood samples. Brief summaries on
these individuals are given below. Selected measurements
are shown in table 1. Five women and seven unaffected
males also participated. Only one obligate carrier (IV-
4) was available. Tissue samples were available on two
additional affected males (III-4 and IV-12).
IV-11 (J. F.) has been institutionalized for mental re-
tardation since age 24 years. Details of the pregnancy
and childhood are not known. His measurements at age
66 years are shown in table 1. He has microcephaly
(occipitofrontal circumference 52.5 cm), and his height
(157.8 cm) is shorter than that of unaffected relatives.
The facies are characterized by central balding, up-slant-
ing palpebral fissures (6.5 on the right, 3.5 on the left),
and short philtrum (fig. 2).
IV-15 (I. F.) had global developmental delay from birth
and has been institutionalized since age 2 years. He is
blind secondary to ocular colobomas and cataracts.
Measurements at age 59 years are shown in table 1.
V-4 (R. H.) had delay of developmental milestones,
with walking at age 2 years and initial speech at age 3
years. He was placed in an institution at age 15 years,
and at present he lives in a group home. Measurements
at age 40 years are given in table 1. R. H. had no speech
but understood simple conversations. The facies was
characterized by central balding, microcephaly, up-slant-
ing palpebral fissures (6 on the right, 5 on the left),
and short philtrum (fig. 2). With the exception of pectus
excavatum, no malformations were noted. There were
partial amputations of four digits on the left hand, be-
cause of an accident.
V-15 (E. F.) was born of a full-term and uncomplicated
pregnancy, experienced global developmental delay, with
walking at age 18 mo, never developed understandable
speech, never attended school, and lives at home. He
had several generalized seizures during childhood. Meas-
urements at age 55 years are shown in table 1. The face
had a squarish configuration, mildly up-slanting pal-
pebral fissures, short philtrum, and everted lower lip (fig.
2). Deep-tendon reflexes were brisk, but clonus was not
present.
V-18 (D. O.) reported that he had attended school for
12 years but had failed each year. He experienced the
same learning difficulties in trade school. He now lives
alone, drives a car, and works as an assistant in a res-
taurant. Measurements at age 44 years are given in table
1. His head was obviously small and measured below
2 SD. He had central balding, up-slanting palpebral
fissures (7 on the right, 6.5 on the left), and nasal
speech. Renpenning et al. (1962) and Fox et al. (1980)
identified individual V-18 as having intellectual function
much higher than that of other affected males in the
family. They considered that he might be mentally im-
paired for some reason other than that which affected
the other males, but they could not establish a cause for
his mental retardation.
In addition to the foregoing information on V-18, re-
ports from the family suggested that mild mental im-
pairment might be present among other males in
branches of the kindred that were not investigated in
this study. A prevailing consideration within the family
was that these younger, mildly affected males might have
the same disorder as affected the older, severely affected
Table 1
Selected Measurements in Kindred 8110
SUBJECT’S CURRENT DESIGNATION
(ORIGINAL DESIGNATION)
AGE(S) AT
EXAMINATION(S)
(years) IQa
PHYSICAL MEASUREMENT (PERCENTILE)a
COMMENTa
Head Circumference
(cm)
Height
(cm)
Ear Length
(cm)
Hand/Palm Length
(cm/cm)
Testicular Volume
(ml)
Affected Males:
III-3 (12) 70 15, 17 49.5 (!3) – ) ) ) Blind,
diabetes
III-4 (13) 64 28 51.4 (!3) ) ) ) )
III-7 (16) 57 13 52.7 (!3) ) ) ) ) Seizures,
diabetes
III-9 (18) 53, 71 17, 27, 39 53.0 (!3) 162.0 (!3) 7.0 (90) ) 2.3/1.0 Diabetes
III-12 (21) 67, 84 35 54.0 (3) 160.0 (!3) 6.5 (55) ) 6.3/6.3
III-16 (24) 60, 77 37 50.0 (!3) 154.0 (!3) 6.5 (55) ) 13.8/12.5
III-19 (27) 54 24 48.3 (!3) ) ) ) ) Diabetes
IV-11 (39) 37, 55, 66 20 52.4 (!3) 157.8 (!3) 6.9 (85) 17.5 (!3)/10.0 7.3/13.1
IV-12 (40) 35, 53 30 53.2 (!3) 171.2 (25) 7.0 (90) ) 23.6/14.7
IV-13 (41) 33, 51 45 50.7 (!3) 155.0 (!3) 7.0 (90) ) 6.3/4.8
IV-15 (43) 30, 49, 59 18 52.2 (!3) 162.5 (!3) 6.7 (70) 17.2 (!3)/9.8 22.4/27.3 Colobomas,
cataracts,
seizures
V-4 (191) 11, 40 30 53.5 (!3) 169.4 (20) 6.4 (45) 18.1 (10)/10.6 ) Pectus
excavatum
V-15 (203) 19, 39, 55 25 55.0 (15) 170.0 (20) 7.3 (97) 19.0 (35)/11.5 13.0/25.2 Seizures
Mild mental impairment:
V-18b (210) 14, 34, 44 70 52.0 (!3) 175.2 (50) 6.3 (35) 19.7 (65)/11.8 15.4/15.3
Not affected:
IV-5 (183) 74 ) 57.0 (60) 177.8 (60) 7.6 (197) 18.5 (20)/10.8 ) )
IV-8 (186) 70 ) 59.1 (95) 177.8 (60) ) 19.6 (60)/11.2 ) )
a Ellipses ()) indicate that an observation was not available.
b Individual has borderline mental retardation and, with regard to the Xp11.2-p11.4 haplotype, is discordant with the more severely males.
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Figure 2 Frontal facial views of, from left to right, IV-11 at age 66 years, showing microcephaly, central balding, and up-slanting palpebral
fissures; V-4 at age 40 years, showing microcephaly, central balding, up-slanting palpebral fissures, and short philtrum ; and V-15 at age 55
years, showing squarish facial configuration, short philtrum, and everted lower lip.
males—but with modified expression, because of the ad-
vantages of schooling and social opportunities. For this
reason, V-18 has been designated by a hatch pattern in
the pedigree shown in figure 1, and, for purposes of
linkage analysis, his condition was considered
“unknown.”
Brain Anatomy
Brain imaging has not been performed, but postmor-
tem examinations of two affected males were available.
Individual III-19 died at age 52 years. The brain weighed
780 g (below the 3d percentile) and showed no devel-
opmental, myelination, or degenerative changes. Indi-
vidual IV-12 died at age 62 year.s The brain weighed
984 g (below the 3d percentile) and showed arachnoid
granulations on the external surface, a small cyst in the
left frontal lobe, and arrangement of the neurons of the
left temporal neocortex in vertical columns, which sug-
gests a defect in neuronal migration or maturation.
Other Laboratory Studies
Renpenning et al. (1962) reported normal chromo-
some analysis (3 cases) and urine amino acid analysis
(14 cases), and Fox et al. (1980) reported absence of the
Xq27.3 fragile site in seven affected males. High-reso-
lution chromosome analysis was normal in IV-6, IV-11,
IV-15, and V-20. Molecular analysis of FMR1 was nor-
mal in IV-15.
Molecular Studies
Genomic DNA was isolated from peripheral blood,
as described elsewhere (Schwartz et al. 1990). Purified
DNA was diluted to a concentration of 105 mg/ml and
was stored at 4C in TE (10 mM Tris-HCl pH 7.6, 1
mM EDTA). For archival material, genomic DNA was
isolated from paraffin-embedded blocks according to the
method described by Sukpanichnant et al. (1993), with
some modifications. Five 10-mm sections were collected
into a 1.5-ml microfuge tube and were deparaffinized in
2 # xylene for 30 min. Subsequently, the sections were
washed in absolute 2 # ethanol for 10 min and were
digested in 50 mM Tris pH 8.5, 1 mM EDTA, 0.5%
Tween 20, and proteinase K (200 mg/ml) for x3 h at
50C. Proteins were removed by extraction using phenol,
phenol/chloroform, and chloroform. The aqueous layer
was removed, ethanol precipitated, and resuspended in
1 # TE. Varying amounts of template DNA were used
for each PCR-microsatellite reaction. Only microsatellite
markers with allele sizes !230 bp were used for ampli-
fication of this material.
For Southern blot analysis, 5 mg of DNA was digested
with various restriction endonucleases, according to the
supplier’s recommendations, and the resulting fragments
were separated on a 0.7% agarose gel and were trans-
ferred to a nylon membrane (MSI). Subsequent prehy-
bridization and hybridizations were performed accord-
ing to the procedure of Schwartz et al. (1990).
For microsatellite analysis, specific dinucleotide or tri-
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Table 2
Two-Point LOD Scores between X Chromosome Loci and RENS1
LOCUS (LOCATION)
LOD SCORE AT RECOMBINATION FRACTION OF
MAXIMUM RE-
COMBINATION
FRCATION
MAXIMUM
LOD
SCORE.001 .01 .05 .1 .2 .3
DXS443 (Xp22.13) 1.48 .53 .06 .21 .21 .10 .15 .23
3’DMD (Xp21.2) 9.97 7.29 4.15 2.75 1.41 .71 .50 .25
DXS1068 (Xp11.4) 5.98 3.01 1.04 .30 .23 .35 .30 .35
DXS8015 (Xp11.4) 3.20 3.15 2.90 2.59 1.93 1.22 .00 3.21
DXS8012 (Xp11.4) 3.04 2.99 2.77 2.49 1.87 1.19 .00 3.04
MAOA (Xp11.3) 1.04 1.02 .93 .81 .59 .38 .00 1.04
DXS8035 (Xp11.3) 3.20 3.15 2.91 2.61 1.96 1.26 .00 3.21
DXS1003 (Xp11.2) 3.13 3.09 2.88 2.61 2.01 1.32 .00 3.13
DXS255 (Xp11.2) 1.60 1.57 1.45 1.29 .94 .54 .00 1.66
DXS1039 (Xp11.2) 1.12 .14 .44 .61 .63 .50 .15 .65
DXS988 (Xp11.2) .25 .25 .21 .17 .09 .03 .00 .26
DXS991 (Xp11.2) .99 .98 .90 .81 .61 .41 .00 1.00
HumARA (Xq12) 1.09 .13 .42 .53 .45 .25 .12 .50
DXS1111 (Xq12) 1.75 1.72 1.58 1.39 .98 .54 .00 1.76
DXS983 (Xq13) .13 1.10 1.66 1.76 1.57 1.16 .10 1.76
DXS566 (Xq13) 13.36 8.34 4.78 3.22 1.69 .84 .50 .16
DXS986 (Xq13) 2.60 2.56 2.36 2.10 1.55 .97 .50 .17
DXS326 (Xq21.2) .77 .75 .66 .55 .33 .12 .00 .77
DXS458 (Xq21) 1.42 .45 .18 .31 .33 .21 .15 .35
DXS456 (Xq22) 4.93 3.04 1.62 .99 .42 .15 .48 .00
DXS424 (Xq24) 7.61 5.10 2.58 1.56 .68 .29 .53 .01
DXS425 (Xq26) 9.26 6.99 3.04 2.53 1.21 .54 .56 .03
HPRT (Xq26) 2.01 1.02 .34 .09 .07 .10 .28 .10
DXS548 (Xq28) 5.08 3.19 1.77 1.15 .55 .25 .55 .01
nucleotide polymorphisms were generated, as reported
by Nelson et al. (1995) or Dib et al. (1996). In most
instances, the forward primers were synthesized and la-
beled with fluorescein amidite (FluorePrime; Pharmacia),
by a Beckman 1000 DNA synthesizer, and were desalted
through a Sephadex G-25 (NAP-10 columns; Pharma-
cia). In some amplifications, the forward primer was
labeled with X-ATP, by use T4 kinase. The polymor-
phisms generated from lymphocyte DNA were detected
by an Automated Laser Fluorescent sequencer (ALF)
(Pharmacia) and the software package Automated Link-
age Preprocessor (ALP) (Mansfield et al. 1994). Ra-
diolabeled amplicons generated from archived DNA
were subjected to electrophoresis on a 6% denaturing
polyacrylamide gel. Autoradiography was at 70C for
3–18 h.
Two-point linkage analysis was conducted by means
of the program MLINK of the LINKAGE package (La-
throp and Lalouel 1984), and multipoint analysis was
by LINKMAP (Lathrop et al. 1985). For the latter, ge-
netic distances were calculated by means of Haldane’s
mapping function, based on previously published re-
combination frequencies (Nelson et al. 1995). The mu-
tation rate and gene frequency were set at 3# 106 and
.0001, respectively. Penetrance was set at 100% for
males and at 0% for females. The status of individual
V-18 was coded as unknown because of his borderline
IQ and normal height.
Results
Two point disease-to-marker linkage analysis using
markers spanning the X chromosome indicated possible
linkage to Xp11.2 and Xq12 (with LOD scores of 1.66
and 1.76 at zero recombination), for DXS255 and
DXS1111, respectively (table 2). Further analysis, using
additional markers in Xp11.2-p11.4, found markers
DXS1003, DXS8015, and DXS8012 to be tightly linked
to the disease (v  .00) with LOD scores of 3.13, 3.21,
and 3.04, respectively, whereas markers in Xq12 (AR
and DXS983) exhibited recombination (table 2 and fig.
3). The combination of these data indicates that the
RENS1 gene is likely located on the proximal short arm
of the X chromosome, in the region flanked by DXS1039
(proximal) and DXS1068 (distal).
Multipoint analysis was used to determine, if possible,
the most likely location for RENS1, within the region
flanked by DXS1039 and DXS1068. The results, as
shown in figure 4, gave a maximum LOD score of 3.45
for a broad region flanked by MAOA and DXS1003.
The region between DXS1039 and DXS1068 covers ∼8
cm, whereas the region between MAOA and DXS1003
covers ∼3 cm (Nelson et al. 1995).
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Figure 3 Haplotype for markers in Xp11-p21. The boxed haplotype segregates with mental retardation. Studies of III-3 and IV-12 used
fixed tissues.
The haplotype for individual V-18, for microsatellite
markers in Xp11.2-11.4, was discordant vis-a`-vis that
of the other more severely impaired males (fig. 3). He is
thus considered not affected, on the basis of this linkage
analysis.
Discussion
During the 1970s, the term “Renpenning syndrome”
came to be used as a generic term for XLMR (Richards
1970; Gerrard and Renpenning 1974; Steele and Chor-
azy 1974; Howard-Peebles et al. 1979; Jennings et al.
1980; McLaughlin and Kriegsmann 1980; Proops and
Webb 1981; Archidiacono et al. 1987). This broad usage
was applied to syndromic XLMR, including fragile X
syndrome, and to nonsyndromic XLMR. Turner et al.
(1970, 1971, 1972) argued that this term should be used
only for nonsyndromic XLMR—specifically, for cases
lacking macrocephaly or microcephaly, epilepsy, major
malformations or more than one minor malformation,
and neurological signs. We propose that these practices
be abandoned and that the term “Renpenning syn-
drome” be reserved for that condition that maps to
Xp11.2-11.4 and is characterized by severe mental im-
pairment, microcephaly, short stature, and small testes.
Those males with XLMR who lack physical, behavioral,
or neurological findings should be designated as having
“nonsyndromic (or “nonspecific”) XLMR,” at least in
the short term, until the responsible genes are isolated.
Robledo et al. (1994) reported evidence for linkage
of RENS1 to markers in both Xp11.23-p11.3 and
Xq21.33-Xq26, in a family previously reported by Ar-
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Figure 4 LOD score of linkage of the RENS1 locus, multipoint
analysis vs. markers in Xp11.2-p21. The genetic distances, calculated
as described in the Subjects and Methods section, were based on the
following recombination frequencies: DXS1068–.025–DXS8015–.07
–DXS8012–.35–MAOA–.01–DXS8035–.065–DXS1003–.055–
DXS255–.01–DXS1039. The multipoint LOD-score values corre-
spond to location scores divided by 4.6.
Table 3
Summary of Reports (Prior to 1970) of X-Linked Conditions in
Which Mental Retardation Was the Predominant Manifestation
Original
Report
Follow-up
Study Syndrome Gene Localization
Martin and
Bell
(1943)
Richards et al.
(1981)
Fragile X Xq27.3 (FMR1)
Allan et al.
(1944)
Schwartz et al.
(1990), Ste-
venson et al.
(1990)
Allan-Herndon-
Dudley
Xq13-q21
Losowsky
(1961)
R. F. Mueller,
personal
communica-
tion
Fragile X Xq27.3 (FMR1)
Renpenning
et al.
(1962)
Fox et al.
(1980), pres-
ent report
Renpenning Xp11.2–p11.4
Dunn et al.
(1962–63)
Fox et al.
(1980)
Fragile X Xq27.3 (FMR1)
Snyder and
Robinson
(1969)
Arena et al.
(1996)
Snyder-Robinson Xp21.3–p22.1
Lubs
(1969)
) Fragile X Xq27.3 (FMR1)
chidiacono et al. (1987). Although a LOD score of 2.71
was found for both locations, the authors considered
one of the two locations to be erroneous and probably
explainable by double recombinations between the dis-
ease and one group of markers.
Localization of RENS1 to Xp11.2-11.4 places the re-
sponsible gene in a region overlapping the localizations
of a number of XLMR syndromes (fig. 5); these include
Prieto (MRXS2), Sutherland-Haan (MRXS3), Porteous,
West, Hamel, Wilson-Turner (MRXS6), and Miles-Car-
penter (MRXS4) syndromes (Sutherland et al. 1988;
Miles and Carpenter 1991; Wilson et al. 1991; Porteous
et al. 1992; Lubs et al. 1996; Prieto et al. 1997; Claes
et al., in press; Hamel et al., in press-a, in press-b). The
genes for monoamine oxidase A deficiency and Norrie
disease are also located in this interval. Renpenning syn-
drome may be distinguished from these conditions on
the basis of physical features, severity of mental im-
pairment, and laboratory testing. Such exclusion must
be considered tenuous, at least with regard to Suther-
land-Haan syndrome, with which Renpenning syndrome
shares several manifestations: short stature, microceph-
aly, and small testes occur in both syndromes. Males
with Sutherland-Haan syndrome may have pectus ex-
cavatum, scoliosis, stiffness of small joints, and pes ca-
vus, skeletal findings that were not noted in the index
family with Renpenning syndrome. This degree of phe-
notypic discordance should not exclude the possibility
that the two conditions arise from mutations of the same
gene.
Likewise, the localization of RENS1 overlaps with
that of a number of families with nonsyndromic XLMR.
Molecular technology has brought the capacity to dis-
tinguish the nonsyndromic XLMR families on the basis
of linkage analysis. Since 1988, 60 families with non-
syndromic XLMR have been assigned “MRX” (i.e.,
mental retardation caused by X-linked genes) numbers
on the basis of linkage analysis, with LOD scores 12.0
(Lubs et al., in press). These families constitute x10
exclusive linkage groups (Gedeon et al. 1996; Lubs et
al. 1996). Since this partition of the X chromosome
leaves room for additional intervening “MRX” condi-
tions and does not preclude the presence of several
“MRX” genes in each linkage group, the total number
of “MRX” conditions cannot be given.
It is quite possible that Renpenning syndrome may be
allelic with one or more of the 23 “MRX” conditions
that overlap the Xp11.2-p11.4 interval (fig. 5). This pos-
sibility can be examined only with identification and
mutational analysis of the RENS1 gene. Until recently,
no gene responsible for nonsyndromal XLMR had been
isolated and characterized. Two genes, the FMR2 gene,
which causes fragile XE syndrome, and the GDI gene,
which causes MRX41 and MRX48, have now been
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Figure 5 Idiogram of Xp11.2-p21.1, showing linkage limits for RENS1 and for Sutherland-Haan, Wilson-Turner, West, Hamel, and Prieto
syndromes and for 23 families with nonsyndromal XLMR (Claes et al., in press; Hamel et al. in press-a, in press-b; Lubs et al., in press). The
megabase marker is according to the study by Nelson et al. (1995).
identified and mapped to Xq28 (Gecz et al. 1996; Gu
et al. 1996; Hamel et al. 1996; des Portes et al. 1997).
Microdeletions in Xp have been described in two fam-
ilies with nonsyndromic XLMR. Billuart et al. (1996)
found a deletion in Xp21.3-22.1 in a 9-year-old boy with
isolated mental retardation, and Raeymaekers et al.
(1996) described a deletion of unknown size in Xp22 in
a family with six males with moderate mental retarda-
tion. Both of these short-arm deletions are located distal
to the RENS1 linkage limits. An X;autosome translo-
cation with a breakpoint in Xp11 has also been asso-
ciated with nonsyndromic XLMR, but the gene inter-
rupted by the translocation has not been isolated (van
der Maarel et al. 1996)
A number of candidate genes located in the linkage
interval must be systematically tested. They include those
for synapsin I (SYNI), GATA-binding protein 1
(GATA1), synaptophysin (SYP), zinc-finger protein 21
(ZNF21, KOX14), zinc-finger protein 81 (HFZ20), tran-
scription factor E3 (TFE3), cell-surface glycoprotein
A15, ubiquitin-activating enzyme E1, and zinc-finger
protein 37 (ZNF31).
With the regional mapping of RENS1, all families with
XLMR that have been reported prior to the initial report
(by Lubs in 1969) of the fragile X syndrome have now
been restudied (table 3). The family reported by Martin
and Bell (1943) was restudied by Richards et al. (1981)
and was shown to have fragile X syndrome. Likewise,
the families reported by Losowsky (1961) and Dunn et
al. (1962–63) have fragile X syndrome (Fox et al. 1980;
R. F. Mueller, personal communication). The Miami-
Greenwood XLMR study group has clinically defined
and mapped the entities reported by Allan et al. (1944),
Snyder and Robinson (1969), and the present report.
The genes responsible for the latter three conditions have
yet to be isolated. It is of interest that four of the seven
families listed in table 3 have fragile X syndrome.
It seems appropriate to conclude with a historical note
regarding the circumstances that, in 1962, led to the
description of this entity. Hans Renpenning was a med-
ical student at the University of Saskatchewan Medical
School (Saskatoon) during the years 1956–60. After his
sophomore year, he worked with Dunn and Gerrard, on
the clinical delineation of a German family in which 20
males with mental retardation had occurred in two gen-
erations. In the course of discussing this project with his
family in the Swift Current area, his father suggested
that he might also study a local Mennonite family in
which a number of males had mental retardation. The
suggestion was followed, and investigation of the family
proceeded rapidly, culminating in the 1962 publication
in the Canadian Medical Association Journal. An article
on the first family being studied with Dunn and Gerrard
was published 6 mo later (Dunn et al. 1962–63). Within
that report is contained the first published photograph
of a patient with the phenotype now recognized as fragile
X syndrome. In light of current understanding of this
syndrome, it is of interest that, in addition to noting
craniofacial features (elongated face with large ears and
prominent lower jaw), the authors found mild expres-
sion in females and suspected transmission of the gene
through a normal male.
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Hans Renpenning thus joins the short list of physicians
and scientists (including Lesch, Klinefelter, and Best)
who made a benchmark contribution to medicine during
their student years. For 30 years, he practiced ophthal-
mology in Saskatoon, retiring in 1995. He now divides
his time between Arizona and Saskatchewan.
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